NL189405C - Farmaceutisch preparaat en gesubstitueerd 1,2-diaminocyclobuteen-3,4-dion met histamine hŸ2-receptor antagonistische werking. - Google Patents

Farmaceutisch preparaat en gesubstitueerd 1,2-diaminocyclobuteen-3,4-dion met histamine hŸ2-receptor antagonistische werking.

Info

Publication number
NL189405C
NL189405C NLAANVRAGE8201999,A NL8201999A NL189405C NL 189405 C NL189405 C NL 189405C NL 8201999 A NL8201999 A NL 8201999A NL 189405 C NL189405 C NL 189405C
Authority
NL
Netherlands
Prior art keywords
diaminocyclobutene
histamine
dione
substituted
pharmaceutical preparation
Prior art date
Application number
NLAANVRAGE8201999,A
Other languages
English (en)
Dutch (nl)
Other versions
NL8201999A (nl
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NL8201999A publication Critical patent/NL8201999A/nl
Application granted granted Critical
Publication of NL189405C publication Critical patent/NL189405C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
NLAANVRAGE8201999,A 1981-05-18 1982-05-13 Farmaceutisch preparaat en gesubstitueerd 1,2-diaminocyclobuteen-3,4-dion met histamine hŸ2-receptor antagonistische werking. NL189405C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26453381 1981-05-18
US06/264,533 US4390701A (en) 1981-05-18 1981-05-18 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione

Publications (2)

Publication Number Publication Date
NL8201999A NL8201999A (nl) 1982-12-16
NL189405C true NL189405C (nl) 1993-04-01

Family

ID=23006472

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8201999,A NL189405C (nl) 1981-05-18 1982-05-13 Farmaceutisch preparaat en gesubstitueerd 1,2-diaminocyclobuteen-3,4-dion met histamine hŸ2-receptor antagonistische werking.

Country Status (37)

Country Link
US (1) US4390701A (el)
JP (2) JPS57193427A (el)
KR (1) KR880000968B1 (el)
AT (1) AT384805B (el)
AU (1) AU541843B2 (el)
BE (1) BE893236A (el)
CA (1) CA1190224A (el)
CH (2) CH649527A5 (el)
CS (1) CS244423B2 (el)
CY (1) CY1446A (el)
DD (1) DD202426A5 (el)
DE (2) DE3249715C2 (el)
DK (1) DK159146C (el)
ES (1) ES8306709A1 (el)
FI (1) FI78695C (el)
FR (2) FR2505835B1 (el)
GB (1) GB2098988B (el)
GR (1) GR75493B (el)
HK (2) HK83288A (el)
HU (2) HU194802B (el)
IE (1) IE53274B1 (el)
IL (1) IL65803A (el)
IT (1) IT1210686B (el)
KE (1) KE3829A (el)
LU (1) LU84157A1 (el)
MY (1) MY8800118A (el)
NL (1) NL189405C (el)
NO (1) NO158419C (el)
NZ (1) NZ200586A (el)
OA (1) OA07103A (el)
PT (1) PT74923B (el)
SE (1) SE457081B (el)
SG (1) SG38388G (el)
SU (1) SU1375127A3 (el)
YU (2) YU43077B (el)
ZA (1) ZA823328B (el)
ZW (1) ZW9782A1 (el)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
US4788184A (en) * 1981-05-18 1988-11-29 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
US4847264A (en) * 1982-07-21 1989-07-11 Rorer Pharmaceutical Corporation Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
AU1956283A (en) * 1982-10-02 1984-04-05 Smith Kline & French Laboratories Limited 1-(3-(4-(substited aminomethyl)pyrid-2-yl-oxy)-prop-1-yl- amino) - 2-aminocyclobut-i-ene-3,4-diones
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4588719A (en) * 1984-04-27 1986-05-13 William H. Rorer, Inc. Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
DE3326545A1 (de) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3404786A1 (de) * 1984-02-10 1985-08-14 Ludwig Heumann & Co GmbH, 8500 Nürnberg Neue alkanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
DE3408327A1 (de) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg Diaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
FR2571723B1 (fr) * 1984-10-12 1988-08-26 Lipha Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
US4785003A (en) * 1984-10-16 1988-11-15 Biomeasure, Inc. N-disubstituted glycine and B-amino-propionic acid derivatives having anti-ulcer activity
US4598067A (en) * 1984-10-16 1986-07-01 Biomeasure, Inc. Antiulcer compounds
US4595757A (en) * 1984-12-13 1986-06-17 American Home Products Corporation N-alkylated benzo- and hetero-fused antisecretory agents
EP0226653B1 (de) * 1985-12-20 1989-02-22 LITEF GmbH Verfahren zur Kurswinkelbestimmung mittels und zur automatischen Kalibration eines in einem Luftfahrzeug fest montierten Dreiachsen-Magnetometers
US4927968A (en) * 1987-05-14 1990-05-22 Bristol-Myers Company Chemical intermediates and process
US4927970A (en) * 1987-05-14 1990-05-22 Bristol-Myers Company Substituted 3-cyclobutene-1,2-dione intermediates
US5112866A (en) * 1988-09-06 1992-05-12 Ortho Pharmaceutical Corporation Ethanesulfonamide derivatives
US5168103A (en) * 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
AU6156894A (en) * 1993-03-09 1994-09-26 Sankyo Company Limited Thienyloxybutenyl derivative
US5506252A (en) * 1993-11-17 1996-04-09 American Home Products Corporation Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5354763A (en) * 1993-11-17 1994-10-11 American Home Products Corporation Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5466712A (en) * 1994-11-04 1995-11-14 American Home Products Corporation Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
US5464867A (en) * 1994-11-16 1995-11-07 American Home Products Corporation Diaminocyclobutene-3,4-diones
US5872139A (en) * 1996-06-17 1999-02-16 American Home Products Corporation Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
US5750574A (en) * 1996-07-17 1998-05-12 American Home Products Corporation Fluorinated N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5763474A (en) * 1996-07-17 1998-06-09 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5846999A (en) * 1996-07-17 1998-12-08 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5780505A (en) * 1996-07-17 1998-07-14 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones
US5840764A (en) * 1997-01-30 1998-11-24 American Home Products Corporation Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones
US6376555B1 (en) 1998-12-04 2002-04-23 American Home Products Corporation 4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
GT200400213A (es) * 2003-10-22 2007-09-05 Metodos para la preparacion del acido {2-[(8,9)-dioxo-2,6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo
CN103242210B (zh) * 2012-02-09 2014-09-24 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer
JP2022085553A (ja) * 2020-11-27 2022-06-08 セイコーエプソン株式会社 可塑化装置、射出成形装置および三次元造形装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3346583A (en) * 1967-10-10 Disubstituted-a-phenethylamines
GB1563090A (en) * 1975-07-31 1980-03-19 Smith Kline French Lab Cyclobutene-diones
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB2001624B (en) 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
GB1604674A (en) * 1977-05-17 1981-12-16 Allen & Hanburys Ltd Aminoalkyl-benzene derivatives
GB1601459A (en) * 1977-05-17 1981-10-28 Allen & Hanburys Ltd Aminoalkyl thiophene derivatives
GB2023133B (en) 1978-04-26 1982-09-08 Glaxo Group Ltd Heterocyclic derivatives
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU8362082A (en) 1982-11-25
KR830009773A (ko) 1983-12-23
CY1446A (en) 1989-03-10
HUT38613A (en) 1986-06-30
FI821698A0 (fi) 1982-05-13
LU84157A1 (fr) 1983-04-13
FR2513250A1 (fr) 1983-03-25
JPS57193427A (en) 1982-11-27
US4390701A (en) 1983-06-28
FR2505835A1 (fr) 1982-11-19
PT74923B (en) 1986-11-13
YU104382A (en) 1985-04-30
ZA823328B (en) 1983-03-30
NO158419B (no) 1988-05-30
SU1375127A3 (ru) 1988-02-15
BE893236A (fr) 1982-11-18
NL8201999A (nl) 1982-12-16
DE3249715C2 (el) 1991-07-11
HU194802B (en) 1988-03-28
SG38388G (en) 1989-01-27
DK159146B (da) 1990-09-10
YU212784A (en) 1985-08-31
JPH0236159A (ja) 1990-02-06
IE53274B1 (en) 1988-09-28
DK219382A (da) 1982-11-19
GB2098988B (en) 1985-07-24
DD202426A5 (de) 1983-09-14
YU43077B (en) 1989-02-28
AT384805B (de) 1988-01-11
ZW9782A1 (en) 1982-12-15
NZ200586A (en) 1985-09-13
GR75493B (el) 1984-07-24
PT74923A (en) 1982-06-01
JPH0251425B2 (el) 1990-11-07
FI78695C (fi) 1989-09-11
AU541843B2 (en) 1985-01-24
IL65803A0 (en) 1982-08-31
CS244423B2 (en) 1986-07-17
JPH0478628B2 (el) 1992-12-11
FR2505835B1 (fr) 1985-11-15
CA1190224A (en) 1985-07-09
ES512279A0 (es) 1983-06-01
DE3218584A1 (de) 1982-12-23
GB2098988A (en) 1982-12-01
NO821586L (no) 1982-11-19
KR880000968B1 (ko) 1988-06-07
CH649527A5 (de) 1985-05-31
KE3829A (en) 1988-12-02
FR2513250B1 (fr) 1986-03-07
MY8800118A (en) 1988-12-31
HK83288A (en) 1988-10-21
ATA197282A (de) 1987-06-15
ES8306709A1 (es) 1983-06-01
HK84688A (en) 1988-10-28
OA07103A (fr) 1987-01-31
DK159146C (da) 1991-02-18
SE457081B (sv) 1988-11-28
DE3218584C2 (el) 1989-11-02
IL65803A (en) 1988-02-29
IT1210686B (it) 1989-09-20
IE821169L (en) 1982-11-18
IT8248435A0 (it) 1982-05-17
CH653989A5 (de) 1986-01-31
SE8203092L (sv) 1982-11-19
FI78695B (fi) 1989-05-31
NO158419C (no) 1988-09-07

Similar Documents

Publication Publication Date Title
NL189405C (nl) Farmaceutisch preparaat en gesubstitueerd 1,2-diaminocyclobuteen-3,4-dion met histamine hŸ2-receptor antagonistische werking.
NL300082I1 (nl) Anthelmintische samenstelling en het gebruik daarvan.
FI884389A (fi) Anordning och foerfarande foer val av inspelning, dess kopiering med stor hastighet och hoeg kvalitet och betalning av royalty foer densamma.
ES2015061B3 (es) Ingrediente antiespuma.
DE58904405D1 (de) 3-aryl-pyrrolidin-2,4-dione.
DE3580304D1 (de) Arzneimittel.
DE3584685D1 (de) Gesinterte nitridverbundkoerper.
DE3671794D1 (de) Lichtschranke.
DE3788385T2 (de) Pyrimidin-Derivate.
DE3783144T2 (de) Infrarotdetektor.
ATE79614T1 (de) Substituierte pyrimidine.
IT1211096B (it) Pirimidine e s.triazinici adattivita' ipolipidemizzante.
IT8123538V0 (it) Bastone, particolarmente per persone debilitate.
ES516118A0 (es) "sillon elevador".
FI824235A0 (fi) Lh-rh-antagonister
DE3786469T2 (de) Infrarotdetektor.
NO890521D0 (no) Substituerte pyrimidiner.
DE3588036D1 (de) 5-Fluoruracilderivate.
DE3575664D1 (de) Selbstschliessende verabreichungsvorrichtung.
NL191744C (nl) Farmaceutisch preparaat met werking tegen epitheelletsels.
DE3881021T2 (de) Stabilisierte Oxymethylen-Copolymer-Zusammensetzung.
IT1235241B (it) Rivelatore d'infrarosso.
DE3763988D1 (de) Sublimierungsvorrichtung.
NL190573B (nl) Farmaceutisch preparaat met diuretische, antihypertensieve en cardiale werking, alsmede 2,4,7-triamino-6-fenylpteridineverbindingen.
DK135184A (da) Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
AK Correction of former applications already laid open

Free format text: IN PAT.BUL.3/84,PAGE 268 NUMBER 8201999 SHOULD BE DELETED

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

V1 Lapsed because of non-payment of the annual fee

Effective date: 19951201